Grindr stock gained 1.00 percent as Freddie deal broadens growth

Published on 10/07/2026 at 01:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Grindr stock rose to USD 13.68 on October 6, while the planned USD 250 million Freddie deal broadens its healthcare strategy. Q2 revenue reached USD 138.138 million.

GRND, US39854F1012, Illustration mit AI erstellt.

Grindr stock (ISIN US39854F1012) was trading at USD 13.68 on the NYSE on October 6, 2026 at 2:39 p.m. ET, up 1.00 percent from the prior close. The company is expanding beyond dating through its planned acquisition of PurposeMed, the parent of HIV prevention provider Freddie.

Healthcare deal adds a new pillar

According to Grindr on September 30, 2026, the transaction values PurposeMed at USD 250 million, comprising USD 190 million in cash and USD 60 million in Grindr stock. The agreement also provides for up to USD 70 million in additional cash tied to 2027 performance targets.

The acquisition is expected to close in Q4 2026 and represents Grindr's first major acquisition since its founding. Freddie expects 2026 revenue above USD 80 million and adjusted EBITDA above USD 10 million, while Grindr says the deal should have an immaterial effect on its 2026 results.

Q2 growth sets the financial base

Grindr generated USD 138.138 million in revenue in Q2 2026, up 33 percent from USD 104.220 million in Q2 2025, according to ceo.ca. Adjusted EBITDA increased to USD 57.640 million from USD 45.207 million, although the adjusted EBITDA margin moved to 41.7 percent from 43.4 percent.

The contrast matters for the healthcare strategy: Grindr is entering a business with additional growth potential, but the acquisition release also says early investment in Freddie's United States infrastructure will weigh on combined margins before scale improves. The company expects more detail on its 2027 outlook with its third-quarter earnings call in November.

Analysts see upside to USD 20

MarketBeat reported on October 4, 2026 that seven brokerages held a Moderate Buy consensus, with six Buy ratings and one Hold rating. The average 12-month price target was USD 20.00, which is 46.2 percent above the USD 13.68 reference price.

That target leaves the market focused on execution. The planned deal adds a health platform to Grindr's subscription and advertising model, while the latest quarterly figures show revenue growth alongside a lower adjusted EBITDA margin.

Grindr stock trades below its yearly high

At USD 13.68 on October 6, 2026, Grindr stock stood 26.1 percent below its 52-week high of USD 18.50 and above its 52-week low of USD 9.73. The next valuation test is whether Freddie can expand Grindr's healthcare reach without slowing the profitability profile shown in Q2.